| I-095 Vincent Duval Pharmacokinetic/Pharmacodynamic framework to support the subcutaneous dosing regimen of nemolizumab in subjects with moderate-to-severe atopic dermatitis. Wednesday 10:20-11:50 |
| I-095 Vincent Duval Pharmacokinetic/Pharmacodynamic framework to support the subcutaneous dosing regimen of nemolizumab in subjects with moderate-to-severe atopic dermatitis. Wednesday 10:20-11:50 |